Ci Private Wealth, LLC Vaxart, Inc. Transaction History

Ci Private Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 26, 2025	SELL	$0.31 - $0.7 $6,145 - $13,877	-19,825 Reduced 50.0%	19,825 $8,000
Q2 2025 Aug 15, 2025	BUY	$0.31 - $0.7 $6,145 - $13,877	19,825 Added 100.0%	39,650 $17,000
Q1 2024 May 09, 2024	SELL	$0.56 - $1.41 $168 - $423	-300 Reduced 1.49%	19,825 $25,000
Q4 2023 Feb 09, 2024	BUY	$0.57 - $0.85 $854 - $1,275	1,500 Added 8.05%	20,125 $11,000
Q3 2023 Nov 03, 2023	BUY	$0.69 - $0.85 $206 - $255	300 Added 1.64%	18,625 $13,000

Q4 2022 Feb 15, 2023	BUY	$0.75 - $2.24 $13,743 - $41,048	18,325 New	18,325 $17,000

4.41M

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $51.9M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ci Private Wealth, LLC with notifications on news.